Michael D'Angelo retweeted
NEWS! Our cell therapy pipeline + our lead candidate for acute liver failure is live! The pipeline consists of multiple txCells with potential to address significant unmet need. The possibilities for novel cures are endless.
#CellTherapy #ALF #ACLF
hubs.ly/Q0288dzG0
Michael D'Angelo retweeted
New blog post:
rrwick.github.io/2023/10/24/…
I revisit the question of ONT-only accuracy for bacterial genomes, and things have improved a lot since I last looked at this about six months ago!
Michael D'Angelo retweeted
Check out the latest preprint from Johnson Lab @LIMSLTU @SABE_latrobe and Piper Lab @MonashSci – a fully synthetic diet that supports #Drosophila development! We demo an application in fly models of human metabolic disorders. #nutrigenomics 🍔🪰🧬biorxiv.org/content/10.1101/…
Michael D'Angelo retweeted
NEWS: Collaboration Announcement
Today, @bitbio announces a collaboration and option agreement with @BlueRockTx for the discovery and manufacture of iPSC-derived regulatory T cells (Tregs) for use in creating therapeutics.🚀
hubs.ly/Q01ZW3yd0
#CellTherapies #Biotech
This is really cool, you can now explore a disease genotype/phenotype association in an isogenic human iPSC system without ever needing to learn how to use CRISPR or culture iPSCs.
(disclaimer - I'm an ex-employee of bit bio and hold shares, but I really do think it's cool!)
BIG NEWS! We launched our new Custom ioDisease Model Cell offering!
Scientists can order their mutation of choice to be genetically engineered in our consistent and defined opti-ox™️ powered human iPSC-derived cells.
hubs.ly/Q01Q-Jgq0
#research #DrugDiscovery #iPSC
Michael D'Angelo retweeted
View from the new office isn’t too shabby though 😊😊😊
Mixed feelings today. Sad to leave @MonashUni Clayton campus after 14 years, 11 as an academic at @MonashBDI and 3 with @oNKo_innate but excited to continue to grow and mature @oNKo_innate at the @BakerResearchAu. Watch this space anyone interested in @AusBiotech
Amazing thread about minipreps. I look forward to trying some of these tricks
Michael D'Angelo retweeted
Looking for a software engineer to join me and the talented team at AusTrakka - Australia's national pathogen genomics surveillance system. Based in Melbourne, Australia at @TheDohertyInst @ @UniMelb . 🇦🇺🦠🧫🧬🖥️ 🌴
jobs.unimelb.edu.au/en/job/9…
Michael D'Angelo retweeted
NEW CELLS! Introducing new precision reprogrammed #FTD #ioDiseaseModelCells and #ioWildTypeCells #ioGABAergicNeurons for early access, ready to be integrated into your neurodegenerative disease research and drug discovery workflows. Read the press release: hubs.ly/Q01t27jY0
Cheap (per run), accurate long reads will be a game-changer
We are pleased to announce that #Flongle R10.4.1 Flow Cells (FLO-FLG114) are available to order on the Store under Early Access. We are delighted to offer our latest and most accurate chemistry to our Flongle users. Learn more: bit.ly/3gLmlCn (login required)
Michael D'Angelo retweeted
Happy International Jumping Spider Day! 🕷️ To celebrate, we have another great citizen science discovery. Donna Juanita photographed this undiscovered species on her property and kindly invited us over to sample it. We later found that it also lives in a nearby nature reserve!
Michael D'Angelo retweeted
Deadline approaching (October 10th) for the postdoctoral position opening in my lab. If you're interested in big questions in human brain development and evolution, please apply!
nature.com/naturecareers/job…
Michael D'Angelo retweeted
NEWS! Product launches to accelerate #research and #drugdiscovery for neurodegenerative disease - models for frontotemporal dementia and amyotrophic lateral sclerosis + early access to our ioMicroglia. Powered by our #cellular #reprogramming tech opti-ox. hubs.ly/Q01nxCSy0
Michael D'Angelo retweeted
Say her name: #MahsaAmini #Mahsa_Amini
Solidarity with #IranianProtests in #Melbourne #womanrights #humanrights
#مهسا_اميني
Michael D'Angelo retweeted
📢We have an opening for a postdoc in my lab! If you are interested in brain organoids and excited about development, evolution, or new technologies, please apply. We have a great record of postdoc success too!
nature.com/naturecareers/job…
RTs much appreciated ☺️
Michael D'Angelo retweeted
So honoured to have contributed to this work, now published in @NatureBiotech! A great work led by @RamyarMolania
Congrats to all the authors!
@TonyPapenfuss @AlexDobrovic et al.
Removing unwanted variation from large-scale RNA sequencing data with PRPS go.nature.com/3BhtaCt
Michael D'Angelo retweeted
BECOME AN EARLY ACCESS TESTER for our human #iPSC -derived, precision reprogrammed ioMicroglia which are consistent, functional, and co-culture compatible with ioGlutamatergic #Neurons, allowing you to gather quality data within just 10 days!
Apply: hubs.ly/Q01lK47-0




















